Finally, safe and effective treatment options for hepatitis C in hemodialysis patients

被引:16
作者
Bhamidimarri, Kalyan Ram [1 ]
Martin, Paul [1 ]
机构
[1] Univ Miami, Miami, FL 33136 USA
关键词
CHRONIC KIDNEY-DISEASE; RENAL-ALLOGRAFTS; VIRAL-INFECTION; VIRUS-INFECTION; SOFOSBUVIR; PHARMACOKINETICS; IMPAIRMENT; CIRRHOSIS;
D O I
10.1016/j.jhep.2016.04.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:7 / 10
页数:4
相关论文
共 28 条
[1]   Hepatitis C virus infection in haemodialysis and kidney transplant patients [J].
Baid-Agrawal, Seema ;
Pascual, Manuel ;
Moradpour, Darius ;
Frei, Ulrich ;
Tolkoff-Rubin, Nina .
REVIEWS IN MEDICAL VIROLOGY, 2008, 18 (02) :97-115
[2]   Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease (vol 63, pg 763, 2015) [J].
Bhamidimarri, Kalyan Ram ;
Czul, Frank ;
Peyton, Adam ;
Levy, Cynthia ;
Hernandez, Maria ;
Jeffers, Lennox ;
Roth, David ;
Schiff, Eugene ;
O'Brien, Christopher ;
Martin, Paul .
JOURNAL OF HEPATOLOGY, 2015, 63 (06) :1542-1542
[3]   Safety, Tolerability, and Pharmacokinetics of Ribavirin in Hepatitis C Virus-Infected Patients with Various Degrees of Renal Impairment [J].
Brennan, B. J. ;
Wang, K. ;
Blotner, S. ;
Magnusson, M. O. ;
Wilkins, J. J. ;
Martin, P. ;
Solsky, J. ;
Nieforth, K. ;
Wat, C. ;
Grippo, J. F. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) :6097-6105
[4]   Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir [J].
Collins, Jeffrey M. ;
Raphael, Kara Loren ;
Terry, Charles ;
Cartwright, Emily J. ;
Pillai, Anjana ;
Anania, Frank A. ;
Farley, Monica M. .
CLINICAL INFECTIOUS DISEASES, 2015, 61 (08) :1304-1306
[5]   Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance [J].
Cruzado, JM ;
Casanovas-Taltavull, T ;
Torras, J ;
Baliellas, C ;
Gil-Vernet, S ;
Grinyó, JM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (03) :357-360
[6]   Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C [J].
Desnoyer, Aude ;
Pospai, Dan ;
Le, Minh Patrick ;
Gervais, Anne ;
Heurgue-Berlot, Alexandra ;
Laradi, Achour ;
Harent, Stanislas ;
Pinto, Adriana ;
Salmon, Dominique ;
Hillaire, Sophie ;
Fontaine, Helene ;
Zucman, David ;
Simonpoli, Anne-Marie ;
Muret, Patrice ;
Larrouy, Lucile ;
Chabert, Brigitte Bernard ;
Descamps, Diane ;
Yazdanpanah, Yazdan ;
Peytavin, Gilles .
JOURNAL OF HEPATOLOGY, 2016, 65 (01) :40-47
[7]   Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients [J].
Espinosa, M ;
Martin-Malo, A ;
de Lara, MAA ;
Ajama, P .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (08) :1669-1674
[8]  
Fabrizi F, 2014, MINERVA UROL NEFROL, V66, P139
[9]  
Frank Czul, 2015, HEPATOLOGY, V62, p726A
[10]  
Gane EJ, 2014, HEPATOLOGY, V60, p667A